The Food and Drug Administration authorized a fresh round of the Moderna or Pfizer and BioNTech COVID-19 vaccinations for those who desire them, more than 34 million Americans aged 50 and over may soon be eligible for another booster dose.
Before physicians can start delivering the extra boosters, the Centers for Disease Control and Prevention must sign off on amended recommendations.
“Current evidence suggests some waning of protection over time against serious outcomes from COVID-19 in older and immuno-compromised individuals,” said Dr. Peter Marks of the FDA.
Previously, only Americans with impaired immune systems have been eligible for a fourth injection if they received the Pfizer-BioNTech or Moderna vaccines first, or a third shot if they received the Johnson & Johnson vaccine first.
The FDA explained that their decision was based on data from Israeli health officials that showed “no new safety concerns” with Pfizer and BioNTech’s vaccine’s fourth dose.
Americans who are old enough will be able to receive their second booster as soon as four months after receiving their first booster.
© Fourth Estate
® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.